1-(3-chlorobenzyl)-1H-indole-3-carbaldehyde, 95.0%, 5g

1-Cyclobutylpyrimidine-2,4(1H,3H)-dione, 98%, 250mg

n-Hexano, min 99%, para síntesis, 1L, envase de vidrio

2H-Benzimidazol-2-one, 1,3-dihydro-5-[3-[4-(phenylmethyl)-1-piperidinyl]-1-propyn-1-yl]-, 98%, 25mg

Methyl 4-chloroquinoline-7-carboxylate, 95.0%, 10g

Metanol D4 con TMS (0,03 vol%), 99,8 at%D, 7,5 ml, envase de vidrioamp.

4-(2-chlorobenzoyl)-8-methyl-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 2g

(S)-N-Methyltetrahydrofuran-3-amine hydrochloride, 95.0%, 100mg

1-(3-fluoro-4-morpholin-4-ylphenyl)ethanone, 97.0%, 250mg

4-(chlorosulfonyl)-3-fluorobenzoic acid, 97.0%, 1g

2,3-Dichloro-4-trifluoromethylpyridine, 95.0%, 250mg

1-(4-Fluorophenyl)urea, 95.0%, 5g

Cyclothiazide (mixture of isomers)>95.0%(HPLC)100mg